An intro to the legal situation for regulatory, pricing and reimbursement in Vietnamese Pharma. Prepared in association with Tilleke & Gibbins, a leading law firm in Vietnam, this is an extract from The Pharma Legal Handbook: Vietnam, available to purchase…
A roundup of some of the biggest pharma and biotech news from China including the collaboration between Elektr and Sinopharm; Biocytogen’s partnership with Janssen and deal with Chipscreen Biosciences; China’s…
In a wide-ranging interview, AbbVie’s Flavio Devoto outlines some of the key access challenges and opportunities in the diverse Latin American pharma market, his approach to being a transformational leader…
The second in a three-part series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come (read part one…
In the current economic environment companies are faced with increased pressure to manage cash and meet investor expectations with tightened budgets. Life science industry CFOs, as a recent survey and…
Belgium, with a total of EUR 5.5 billion in R&D spending in 2021, is the country with the fourth largest research expenditure in the EU and the first per inhabitant. …
PharmaBoardroom’s latest report, InFigures: Asia Pacific 2023 features up-to-date datasets from the region’s leading pharma markets and regional innovation hubs. Covering everything from population health to market growth, company rankings,…
Christian Rodseth, VP and managing director for Janssen’s Greece, Poland, and Romania cluster, outlines the multifaceted strengths of his teams, the part of the Janssen portfolio he is most excited to bring to the region, and the policy measures needed to ensure that Greek healthcare remains sustainable and able to support innovation. My team and I are constantly focused…
In a wide-ranging interview, AbbVie’s Flavio Devoto outlines some of the key access challenges and opportunities in the diverse Latin…
The much-discussed implementation of an EU-wide legislative framework on health technology assessment (HTA) will finally come to fruition in 2025,…
A roundup of recent pharma and healthcare news from Vietnam including Gilead's viral hepatitis initiative, the country's explosion of dengue fever cases and the investigation into Boston Scientific's Vietnam operations.…
MSD is set to inject an additional USD 500 million into its existing Singapore manufacturing operations with two new facilities to produce vaccines and biologics. One of the new plants…
The biggest pharma stories from Southeast Asia, including GSK's new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia's acute kidney injury crisis, Kalbe's Aventis share…
Takeda gets a first approval for QDENGA, its dengue vaccine, which has been given the green light by the Indonesian National Agency for Drug and Food Control, Badan Pengawas Obat…
A roundup of the latest pharma news from the United Arab Emirates (UAE) including Julpher's pursuit of its growth strategy with a new CEO, Global Pharma's tech transfer deal with…
The healthcare and life sciences industry is well represented in Forbes Middle East’s 100 Most Powerful Businesswomen 2023 list alongside sectors such as banking, investments, and retail. In a region…
The second in a three-part series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come (read part one…
The latest news from the Saudi healthcare and life science industry, including how the implementation of COVID-19 measures have helped reduce the prevalence of MERS-CoV in the country, regulatory approval…
DEMO, founded in 1965, is a mainstay of Greek pharma and one of its largest companies, accounting for 25 percent of the total investment across the entire Greek pharmaceutical sector.…
The European Medicines Agency (EMA) recently published its annual Human Medicines Highlights report, documenting key figures on its recommendations for the authorisation of new medicines in 2022. The Agency gave…
Edward Mc Gettrick and Sharon Gorman of Pfizer, writing in the January 2023 edition of DIA’s Global Forum magazine, examine the scope and impact of the European Union's new Regulation on…
Some of the most important stories emanating from the Central and Eastern European (CEE) region’s pharma industry, including Polpharma's bid for Zentiva, Richter's acquisition of OC Distributors and MDD approval…
In 2019 the pharma industry financed some 700 clinical studies in Latin America with investments of more than USD one billion and according to FIFARMA, the leading association of innovators…
Mexico, with the second largest pharmaceutical market in Latin America, has a number of strong local pharma industry players. These companies, no longer focused solely on the domestic market, are…
Latin America is renowned for its creative geniuses – think footballers like Lionel Messi and Pelé; magical realist authors such as Gabriel García Márquez and Isabel Allende; and ground-breaking artists…
After gaining its first global approval in Indonesia, Takeda’s dengue fever vaccine, Qdenga, recently got a green light from the European Commission (EC) to market the vaccine in Europe, laying…
See our Cookie Privacy Policy Here